# CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

> **NCT04053543** · PHASE2 · TERMINATED · sponsor: **Complexa, Inc.** · enrollment: 33 (actual)

## Conditions studied

- PAH

## Interventions

- **DRUG:** CXA-10

## Key facts

- **NCT ID:** NCT04053543
- **Lead sponsor:** Complexa, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-09
- **Primary completion:** 2020-08-12
- **Final completion:** 2020-08-12
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** LOE
- **Last updated:** 2020-08-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053543, "CXA-10 Study in Subjects With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04053543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*